Nifty
:
23851.65
Sensex
:
78553.20
414.45 (1.77%)
1508.91 (1.96%)
Menu
Nifty
Sensex
:
:
23851.65
78553.20
414.45 (1.77%)
1508.91 (1.96%)

Samrat Pharmachem Ltd.

Pharmaceuticals & Drugs

Rating :
N/A

BSE: 530125 | NSE: Not Listed

NSE BSE
361.60
06-Feb-2025
  • Open
  • High
  • Low
  • Previous Close
  •  367.65
  •  367.65
  •  356.00
  •  354.65
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  910
  •  3.32
  •  646.00
  •  302.05

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 105.31
  • 11.82
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 107.57
  • 0.29%
  • 1.46

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 49.09%
  • 2.59%
  • 41.58%
  • FII
  • DII
  • Others
  • 0%
  • 3.24%
  • 3.50%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 19.24
  • 15.42
  • 8.29

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 7.94
  • -17.92
  • -36.67

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 21.04
  • -12.62
  • -49.90

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 11.79
  • 11.65
  • 11.46

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.28
  • 2.33
  • 2.48

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 11.50
  • 14.38
  • 18.94

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated
Description
Dec 24
Dec 23
Var%
Sep 24
Sep 23
Var%
Jun 24
Jun 23
Var%
Mar 24
Mar 23
Var%
Net Sales
63.66
61.67
3.23%
70.17
79.75
-12.01%
80.82
57.48
40.61%
82.68
69.18
19.51%
Expenses
59.49
61.56
-3.36%
66.81
79.51
-15.97%
78.24
56.71
37.97%
81.33
69.67
16.74%
EBITDA
4.17
0.11
3,690.91%
3.36
0.23
1,360.87%
2.58
0.77
235.06%
1.36
-0.49
-
EBIDTM
6.55%
0.18%
4.79%
0.29%
3.20%
1.34%
1.64%
-0.71%
Other Income
0.00
0.42
-100.00%
0.49
0.30
63.33%
0.59
0.36
63.89%
0.30
0.03
900.00%
Interest
0.10
0.23
-56.52%
0.16
0.13
23.08%
0.19
0.22
-13.64%
0.11
0.17
-35.29%
Depreciation
0.17
0.16
6.25%
0.17
0.16
6.25%
0.16
0.16
0.00%
0.16
0.16
0.00%
PBT
3.91
0.14
2,692.86%
3.52
0.24
1,366.67%
2.82
0.75
276.00%
1.39
-0.79
-
Tax
1.13
-0.20
-
0.86
0.43
100.00%
0.75
0.14
435.71%
-0.01
-0.05
-
PAT
2.79
0.34
720.59%
2.66
-0.19
-
2.06
0.61
237.70%
1.40
-0.75
-
PATM
4.37%
0.56%
3.79%
-0.24%
2.55%
1.06%
1.69%
-1.08%
EPS
8.98
1.11
709.01%
8.58
-0.61
-
6.66
1.97
238.07%
4.50
-2.40
-

Annual Results

Standalone Figures in Rs. Crores

Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Net Sales
297.33
281.58
310.65
221.75
179.02
137.45
111.14
92.94
72.75
63.20
48.47
Net Sales Growth
10.91%
-9.36%
40.09%
23.87%
30.24%
23.67%
19.58%
27.75%
15.11%
30.39%
 
Cost Of Goods Sold
276.89
270.32
277.86
189.90
164.25
125.62
102.61
81.60
62.78
56.32
42.89
Gross Profit
20.44
11.26
32.78
31.85
14.77
11.84
8.52
11.34
9.97
6.88
5.59
GP Margin
6.88%
4.00%
10.55%
14.36%
8.25%
8.61%
7.67%
12.20%
13.70%
10.89%
11.53%
Total Expenditure
285.87
279.11
286.72
197.51
170.35
130.82
107.96
86.99
69.07
62.00
47.32
Power & Fuel Cost
-
1.37
1.46
1.34
1.12
0.91
0.73
0.82
0.66
0.74
0.75
% Of Sales
-
0.49%
0.47%
0.60%
0.63%
0.66%
0.66%
0.88%
0.91%
1.17%
1.55%
Employee Cost
-
1.11
1.07
0.96
1.05
1.00
0.94
0.85
0.76
0.66
0.62
% Of Sales
-
0.39%
0.34%
0.43%
0.59%
0.73%
0.85%
0.91%
1.04%
1.04%
1.28%
Manufacturing Exp.
-
2.17
2.51
2.38
1.71
1.28
1.46
1.31
1.50
1.20
0.67
% Of Sales
-
0.77%
0.81%
1.07%
0.96%
0.93%
1.31%
1.41%
2.06%
1.90%
1.38%
General & Admin Exp.
-
2.55
2.11
1.73
1.11
1.17
1.20
1.10
0.93
0.87
0.85
% Of Sales
-
0.91%
0.68%
0.78%
0.62%
0.85%
1.08%
1.18%
1.28%
1.38%
1.75%
Selling & Distn. Exp.
-
1.25
1.43
1.02
0.79
0.75
1.01
1.30
2.27
2.21
1.54
% Of Sales
-
0.44%
0.46%
0.46%
0.44%
0.55%
0.91%
1.40%
3.12%
3.50%
3.18%
Miscellaneous Exp.
-
0.35
0.27
0.18
0.32
0.09
0.01
0.01
0.15
0.00
1.54
% Of Sales
-
0.12%
0.09%
0.08%
0.18%
0.07%
0.01%
0.01%
0.21%
0%
0.02%
EBITDA
11.47
2.47
23.93
24.24
8.67
6.63
3.18
5.95
3.68
1.20
1.15
EBITDA Margin
3.86%
0.88%
7.70%
10.93%
4.84%
4.82%
2.86%
6.40%
5.06%
1.90%
2.37%
Other Income
1.38
1.38
0.48
0.63
0.46
0.57
0.46
0.25
0.16
0.21
0.36
Interest
0.56
0.69
1.23
0.67
1.28
0.98
1.06
0.86
0.63
0.51
0.59
Depreciation
0.66
0.65
0.64
0.59
0.49
0.43
0.42
0.41
0.43
0.44
0.44
PBT
11.64
2.52
22.53
23.60
7.36
5.80
2.16
4.92
2.78
0.45
0.49
Tax
2.73
0.36
5.90
6.42
2.01
1.55
0.62
1.70
1.02
0.15
0.16
Tax Rate
23.45%
14.29%
26.19%
27.20%
27.38%
26.77%
28.70%
34.55%
36.69%
33.33%
34.04%
PAT
8.91
2.16
16.63
17.18
5.33
4.24
1.54
3.22
1.75
0.30
0.32
PAT before Minority Interest
8.91
2.16
16.63
17.18
5.33
4.24
1.54
3.22
1.75
0.30
0.32
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
3.00%
0.77%
5.35%
7.75%
2.98%
3.08%
1.39%
3.46%
2.41%
0.47%
0.66%
PAT Growth
89,000.00%
-87.01%
-3.20%
222.33%
25.71%
175.32%
-52.17%
84.00%
483.33%
-6.25%
 
EPS
28.74
6.97
53.65
55.42
17.19
13.68
4.97
10.39
5.65
0.97
1.03

Results Balance Sheet

Standalone Figures in Rs. Crores

Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Shareholder's Funds
65.00
63.14
46.82
29.64
24.30
20.07
18.53
15.31
13.76
13.45
Share Capital
3.09
3.09
3.09
3.09
3.09
3.09
3.09
3.09
3.09
3.09
Total Reserves
61.91
60.05
43.73
26.55
21.21
16.98
15.44
12.22
10.67
10.37
Non-Current Liabilities
0.34
0.25
0.46
0.43
0.14
0.83
1.27
1.66
1.96
0.68
Secured Loans
0.00
0.00
0.00
0.00
0.00
0.31
0.76
1.17
1.53
0.26
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Current Liabilities
56.40
53.19
37.33
27.33
33.90
19.33
21.02
19.10
20.46
12.12
Trade Payables
47.67
31.88
23.39
17.66
23.15
12.66
10.40
7.30
16.09
8.93
Other Current Liabilities
0.28
0.52
0.89
0.17
0.44
0.53
1.00
5.79
0.57
0.58
Short Term Borrowings
8.45
18.66
7.52
8.79
9.10
5.77
8.22
5.42
3.70
2.61
Short Term Provisions
0.00
2.14
5.53
0.70
1.22
0.37
1.41
0.60
0.10
0.00
Total Liabilities
121.74
116.58
84.61
57.40
58.34
40.23
40.82
36.07
36.18
26.25
Net Block
10.72
10.70
9.99
9.40
7.19
6.86
6.99
7.01
7.28
7.22
Gross Block
16.62
16.25
14.89
14.00
11.44
10.92
10.62
10.24
9.81
9.40
Accumulated Depreciation
5.89
5.55
4.91
4.60
4.25
4.05
3.63
3.22
2.53
2.17
Non Current Assets
19.17
17.54
13.35
10.07
8.67
7.47
7.56
7.79
7.81
7.77
Capital Work in Progress
0.00
0.00
0.00
0.00
1.08
0.00
0.00
0.20
0.00
0.00
Non Current Investment
2.92
1.86
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Loans & Adv.
1.47
0.91
0.80
0.65
0.40
0.51
0.49
0.51
0.44
0.47
Other Non Current Assets
4.06
4.06
2.56
0.02
0.00
0.10
0.08
0.06
0.08
0.08
Current Assets
102.57
99.05
71.26
47.32
49.68
32.76
33.27
28.30
28.37
18.48
Current Investments
0.01
0.01
0.01
0.00
0.00
0.00
0.00
0.00
2.00
0.00
Inventories
20.68
32.53
12.42
11.40
18.77
7.93
6.85
7.02
5.68
4.47
Sundry Debtors
69.28
51.67
43.57
33.01
27.81
21.05
21.89
11.84
16.10
9.62
Cash & Bank
9.73
11.89
14.71
2.51
1.17
2.25
3.98
2.44
3.50
3.94
Other Current Assets
2.87
0.06
0.07
0.38
1.93
1.53
0.55
7.00
1.09
0.45
Short Term Loans & Adv.
2.80
2.88
0.49
0.03
1.10
0.02
0.07
0.07
0.25
0.03
Net Current Assets
46.16
45.86
33.93
20.00
15.78
13.43
12.24
9.19
7.90
6.37
Total Assets
121.74
116.59
84.61
57.39
58.35
40.23
40.83
36.09
36.18
26.25

Cash Flow

Standalone Figures in Rs. Crores

Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Cash From Operating Activity
9.41
-9.44
17.47
4.80
-1.33
2.37
0.13
-3.23
-0.36
-0.56
PBT
2.52
22.53
23.60
7.34
5.79
2.16
4.92
2.78
0.45
0.48
Adjustment
0.03
1.65
1.19
1.70
1.39
1.40
1.17
1.12
0.83
0.86
Changes in Working Capital
9.27
-24.12
-5.78
-1.99
-7.62
0.47
-5.08
-6.57
-1.07
-1.10
Cash after chg. in Working capital
11.82
0.06
19.01
7.05
-0.45
4.03
1.01
-2.68
0.21
0.25
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
-0.51
-0.59
Tax Paid
-2.41
-9.50
-1.53
-2.25
-0.87
-1.65
-0.88
-0.55
-0.06
-0.22
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-0.41
-3.00
-1.06
-2.92
-1.92
2.18
-2.44
1.23
-2.38
0.01
Net Fixed Assets
-0.37
-1.36
-0.89
-1.48
-1.60
-0.30
-0.18
-0.63
-0.41
-0.06
Net Investments
-1.06
-1.86
-0.01
0.00
0.00
0.00
0.00
2.00
-2.00
0.00
Others
1.02
0.22
-0.16
-1.44
-0.32
2.48
-2.26
-0.14
0.03
0.07
Cash from Financing Activity
-11.20
9.60
-1.95
-1.89
2.00
-3.92
1.53
0.72
2.30
0.12
Net Cash Inflow / Outflow
-2.19
-2.84
14.46
-0.02
-1.25
0.63
-0.78
-1.28
-0.44
-0.43
Opening Cash & Equivalents
11.86
14.71
0.24
0.26
1.50
0.87
1.65
2.93
3.94
2.28
Closing Cash & Equivalent
9.67
11.86
14.71
0.24
0.26
1.50
0.87
1.65
3.50
1.84

Financial Ratios

Standalone

Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Book Value (Rs.)
210.37
204.37
151.54
95.92
78.66
64.95
59.98
49.57
44.52
43.55
ROA
1.81%
16.53%
24.20%
9.22%
8.60%
3.79%
8.37%
4.86%
0.97%
1.10%
ROE
3.38%
30.25%
44.95%
19.77%
19.10%
7.96%
19.01%
12.07%
2.21%
2.38%
ROCE
4.13%
34.91%
52.33%
23.90%
22.43%
11.80%
23.05%
16.40%
5.31%
6.45%
Fixed Asset Turnover
17.13
19.95
15.35
16.07
14.06
11.64
10.10
7.84
7.11
5.61
Receivable days
78.39
55.96
63.02
54.31
56.75
62.50
58.43
64.90
68.75
72.43
Inventory Days
34.48
26.40
19.60
26.94
31.01
21.51
24.02
29.49
27.12
41.52
Payable days
53.71
36.30
39.45
45.34
52.01
38.75
36.89
61.12
73.14
93.97
Cash Conversion Cycle
59.17
46.06
43.17
35.91
35.75
45.27
45.57
33.27
22.73
19.97
Total Debt/Equity
0.13
0.30
0.16
0.30
0.39
0.33
0.51
0.45
0.40
0.24
Interest Cover
4.67
19.29
35.99
6.75
6.91
3.04
6.70
5.37
1.88
1.82

Annual Reports:

FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016

News Update:


  • Samrat Pharmachem - Quarterly Results
    14th Feb 2025, 15:42 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.